Interview Intersection: Expert Interviews From September 2025

Innovation and Aesthetic Science

Beyond Bad Habits: Understanding and Treating Dermatillomania and Trichotillomania

Sofia Wenzler, PhD, addresses misconceptions about dermatillomania (skin picking) and trichotillomania (hair pulling), advocating for compassionate care and accessible treatment for BFRBs.

• MORE FROM WENZLER: How Dermatologists Can Treat the Mind-Body Connection in BFRBs

Balancing Efficacy and Tolerability in Retinoid Therapy

Novel formulations like retinal-infused exosomes represent an evolution rather than a replacement of retinoid therapy.

• MORE FROM GOLD: Clinical Trials Support New Retinal Formulation Tolerability

The Science Behind a Topical Glutathione Delivery System

Discover how Auro GSH by Nayan Patel, PharmD, revolutionizes glutathione delivery in skin care, targeting oxidative stress for healthier skin.

• MORE FROM PATEL: Unlocking Skin's Potential from the Inside Out with Glutathione

Clinical Updates

Selective JAK Inhibition With Deuruxolitinib Restores Hair Growth in Alopecia Areata

Vimal Prajapati, MD, FRCPC, DABD, reviews the mechanism of action, clinical trial outcomes, monitoring considerations, and safety profile of recently available deuruxolitinib.

• MORE INSIGHTS FROM PRAJAPATI: Integrating Deuruxolitinib Into Clinical Practice for Severe Alopecia Areata

Alexa Kimball, MD, on the Future of HS Care

HS management is shifting toward earlier diagnosis and intervention to prevent long-term scarring and disability.

• MORE FROM KIMBALL: Efficacy Gaps Remain Despite Therapeutic Advances in HS

Beyond the Myths: Expert Data Updates on Acne and Rosacea Management

Discover key insights from Maui Derm NP+PA Fall 2025 on acne and rosacea treatments, featuring expert strategies from Hilary Baldwin, MD.

A Look at Blistering Diseases and Beyond with Margaret Bobonich, DNP, FNP-C, DCNP, FAAN

Discover educational insights on blistering diseases and innovative treatments like dupilumab at the Maui Derm NP+PA Fall 2025 conference.

Apex Skin Expands Access and Representation in Dermatology Research

Jorge Garcia-Zuazaga, MD, MBA, FAAD, FACMS, shares how Apex Skin’s multi-site model advances clinical trial access, diversity, and execution.

Unique Perspectives

A Paradigm Shift in Psoriasis Care: Almirall's POSITIVE Study and the Focus on Patient Well-Being

Almirall's POSITIVE study, presented at EADV 2025, prioritizes patient well-being, showcasing the holistic impact of advanced treatments.

Expert Insights on Uncommon Dermatoses from Walter Liszewski, MD

Discover expert insights on treating uncommon conditions like lichen planus, CSU, and polymorphous light eruption from Maui Derm NP+PA Fall 2025.

• MORE FROM LISZEWSKI: The Latest in Contact Dermatitis and AD at Maui Derm NP+PA Fall

Empowering Providers and Expanding the Toolbox in Dermatology

Kara Mudd, PA-C, shares vital insights on atopic dermatitis, rosacea, and contact dermatitis from Maui Derm NP+PA Fall 2025, enhancing clinical practice.

Conference Spotlights

Peter Lio, MD, at EADV 2025: Rethinking the Atopic Dermatitis Journey

Major unmet needs in pediatric AD include rapid itch relief, access, affordability, and better options for sensitive skin.

Bunick Discusses Dual-Target Biologic at EADV 2025

Galvokamig, a biologic targeting IL-13 and IL-17A/F, demonstrated significant benefits in moderate to severe atopic dermatitis.

• MORE FROM BUNICK: 6-Year Data Support Long-Term Safety of Upadacitinib

Inside the Maui Derm NP+PA Fall 2025 Conference with George Martin, MD

Preview the Maui Derm NP+PA Fall 2025 Conference with program director George Martin, MD, featuring cutting-edge education and expert insights in Nashville.

• MORE FROM MARTIN: A Review of the Latest Drug Developments at Maui Derm NP+PA Fall 2025, Navigating Non-Surgical Options in Cutaneous Oncology, A Practical Update on Psoriasis and Vitiligo Treatment

Elena Hawryluk, MD, PhD, on the Value of Continuing Education at Maui Derm NP+PA Fall 2025

Elena Hawryluk, MD, PhD, highlights innovative pediatric dermatology at Maui Derm NP+PA Fall, emphasizing education and advancements in tumor genetics.

• MORE FROM HAWRYLUK: Evolving Pediatric Melanoma Care at Maui Derm NP+PA Fall 2025

The Future of AD Treatment and Pediatric Care with Leigh Ann Pansch, MSN, FNP-C, DCN

Discover the latest advancements in pediatric dermatology and atopic dermatitis treatments from Maui Derm NP+PA Fall 2025, featuring expert insights and emerging therapies.

Reflections and Highlights

A Closer Look at Ruxolitinib’s Pediatric AD Approval with Nicole Harter, MD

Nicole Harter, MD, explores ruxolitinib 1.5% cream for pediatric atopic dermatitis, offering a novel, effective treatment option for children aged 2 to 11.

• MORE ON RUXOLITINIB'S APPROVAL: How Ruxolitinib’s Expanded Indication Will Impact Pediatric Patients With AD, FDA Approval Brings New Nonsteroidal Option for Pediatric AD

Guttman-Yassky Showcases 2 Paths to Long-Term AD Control at EADV 2025

At EADV 2025, she showcased how OX40 and JAK inhibition offer complementary approaches to long-term disease control.

• MORE FROM GUTTMAN-YASSKY: Guttman-Yassky Discusses APG777 as a Potential Breakthrough in AD

Douglas DiRuggiero, DMSc, MHS, PA-C, on the Evolving Landscape of Dermatologic Care

Discover key insights from the Maui Derm NP+PA Fall 2025 Conference on advances in dermatology, including new treatments and research findings.

Psoriasis Insights and Professional Pride with Stephanie Simmerman, DNP, APRN-C

Stephanie Simmerman, DNP, APRN-C, led discussions on psoriasis treatment innovations at Maui Derm NP+PA Fall 2025, highlighting NP and PA advancements.

Don’t miss a moment of Dermatology Times by signing up for our eNewsletters and subscribing to receive the free print issue and supplements each month.